Holen Sie sich die Stockscreener-App
3.7229
2.61%
0.0879
Schlusskurs vom Vortag:
$3.635
Offen:
$3.65
24-Stunden-Volumen:
495.46K
Relative Volume:
0.90
Marktkapitalisierung:
$359.41M
Einnahmen:
$97.06M
Nettoeinkommen (Verlust:
$-130.39M
KGV:
-2.1645
EPS:
-1.72
Netto-Cashflow:
$-186.54M
1W Leistung:
-24.03%
1M Leistung:
-19.09%
6M Leistung:
-30.80%
1J Leistung:
-21.97%
1-Tages-Spanne:
$3.49
$3.78
1-Wochen-Bereich:
$3.49
$5.01
52-Wochen-Spanne:
$3.49
$8.90
Alector Inc Stock (ALEC) Company Profile
Firmenname
Alector Inc
Sektor
Branche
Telefon
415-231-5660
Adresse
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Vergleichen Sie ALEC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| ALEC | 3.73 | 359.41M | 97.06M | -130.39M | -186.54M | -1.72 |
| VRTX | 449.64 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 748.66 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 589.18 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 248.13 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 106.50 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-09-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-07-07 | Eingeleitet | Mizuho | Buy |
| 2022-04-13 | Eingeleitet | Goldman | Sell |
| 2022-03-08 | Herabstufung | Stifel | Buy → Hold |
| 2021-09-27 | Eingeleitet | William Blair | Outperform |
| 2021-01-15 | Fortgesetzt | BofA Securities | Buy |
| 2020-06-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-28 | Eingeleitet | Goldman | Buy |
| 2020-03-06 | Eingeleitet | Citigroup | Buy |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-02-19 | Eingeleitet | Stifel | Buy |
| 2019-11-21 | Eingeleitet | BTIG Research | Buy |
| 2019-03-04 | Eingeleitet | Barclays | Overweight |
| 2019-03-04 | Eingeleitet | BofA/Merrill | Buy |
| 2019-03-04 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-03-04 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Alector Inc Aktie (ALEC) Neueste Nachrichten
Goldman Sachs maintains sell on Alector, target $4 amid Alzheimer's study - Investing.com India
Alector stock hits 52-week low at $4.05 amid market challenges - Investing.com Canada
Alector, Inc. (NASDAQ:ALEC) Shares Sold by US Bancorp DE - Defense World
Alector (ALEC) Reports Q3 Loss, Misses Revenue Estimates - MSN
Alector, Inc. announced that it expects to receive $50 million in funding from Hercules Capital, Inc., and other investors - Marketscreener.com
Alector secures $50 million credit facility from Hercules Capital - Investing.com India
Alector secures $50 million credit facility from Hercules Capital By Investing.com - Investing.com Canada
ALECAlector, Inc. Latest Stock News & Market Updates - StockTitan
Alector Secures Flexible Credit Facility for Up to $50 Million From Hercules Capital - GlobeNewswire
Alector, Inc. Secures Flexible Credit Facility for Up to $50 Million from Hercules Capital, Inc - Marketscreener.com
Alector, Inc. (NASDAQ:ALEC) Position Reduced by Baillie Gifford & Co. - MarketBeat
Alector (ALEC) Shares Plunge Amid Industry Volatility - GuruFocus.com
Creative Planning Increases Position in Alector, Inc. (NASDAQ:ALEC) - Defense World
FY2024 Earnings Forecast for Alector Issued By HC Wainwright - Defense World
William Blair Has Strong Outlook for Alector FY2024 Earnings - Defense World
Alector (NASDAQ:ALEC) Earns Buy Rating from HC Wainwright - Defense World
FY2024 Earnings Estimate for Alector Issued By HC Wainwright - MarketBeat
FY2024 Earnings Estimate for Alector Issued By William Blair - MarketBeat
Alector (NASDAQ:ALEC) Announces Earnings Results, Beats Estimates By $0.10 EPS - MarketBeat
Head to Head Review: Alector (NASDAQ:ALEC) vs. BioAtla (NASDAQ:BCAB) - Defense World
Alector Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Simply Wall St
Morgan Stanley's Strategic Reduction in Alector Inc Shares - GuruFocus.com
Alector (NASDAQ:ALEC) Earns "Buy" Rating from HC Wainwright - MarketBeat
Alector: Q3 Earnings Snapshot - The Bakersfield Californian
Alector Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
Alector earnings beat by $0.10, revenue fell short of estimates - Investing.com Canada
Alector (NASDAQ:ALEC) Trading 7% HigherTime to Buy? - MarketBeat
Precision BioSciences (DTIL) Surges 6.1%: Is This an Indication of Further Gains? - Yahoo Finance
Is Alector (NASDAQ:ALEC) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Alector, Inc. (NASDAQ:ALEC) Short Interest Update - MarketBeat
SG Americas Securities LLC Sells 33,430 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector, Inc.'s (NASDAQ:ALEC) Business And Shares Still Trailing The Industry - Simply Wall St
Alector, Inc. (NASDAQ:ALEC) Short Interest Up 19.9% in September - MarketBeat
Cubist Systematic Strategies LLC Purchases 38,947 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
Marshall Wace LLP Lowers Position in Alector, Inc. (NASDAQ:ALEC) - MarketBeat
Was anything negative for Alector Inc (ALEC) stock last session? - US Post News
Dimensional Fund Advisors LP Has $3.07 Million Stock Position in Alector, Inc. (NASDAQ:ALEC) - MarketBeat
Alector Inc [ALEC] Chief Financial Officer makes an insider sale of 7,297 shares worth 35,620. - Knox Daily
The Future of Alector Inc: Analyzing ALEC - The InvestChronicle
Alector (ALEC) Stock Surges Over 5% Amid Positive Institutional Ratings - GuruFocus.com
ProShare Advisors LLC Sells 4,070 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
Insider’s View: Deciphering Alector Inc (ALEC)’s Financial Health Through Ratios - The Dwinnex
Frontotemporal Dementia Pipeline 2024: Clinical Trials - openPR
Frontotemporal Dementia Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | Alector, Oncolys BioPharma, Denali Therapeutics, Passage Bio - Barchart
Recent Insider Activity Suggests Potential Gains for Alector Inc (ALEC) - Knox Daily
Cubist Systematic Strategies LLC Has $419,000 Stock Holdings in Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector, Inc. (NASDAQ:ALEC) Shares Sold by American Century Companies Inc. - Defense World
Alector Inc (ALEC) Stock: A Year of Declines and Increases - The InvestChronicle
Check out these key findings about Alector Inc (ALEC) - SETE News
View On Upcoming Q4 Biotech Catalysts: Part 1 (ALEC, ARVN, AMLX) (NASDAQ:ALEC) - Seeking Alpha
Examining Alector Inc (ALEC) stock is warranted - US Post News
Finanzdaten der Alector Inc-Aktie (ALEC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):